Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Free Cash Flow: 2009-2024

Historic Free Cash Flow for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to $4.6 million.

  • OptimizeRx's Free Cash Flow rose 8648.81% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 123473.17%. This contributed to the annual value of $4.6 million for FY2024, which is 15671.73% up from last year.
  • Latest data reveals that OptimizeRx reported Free Cash Flow of $4.6 million as of FY2024, which was up 15671.73% from -$8.0 million recorded in FY2023.
  • Over the past 5 years, OptimizeRx's Free Cash Flow peaked at $10.5 million during FY2022, and registered a low of -$8.0 million during FY2023.
  • Its 5-year average for Free Cash Flow is $200192.8, with a median of $361873.0 in 2021.
  • Per our database at Business Quant, OptimizeRx's Free Cash Flow plummeted by 26479.15% in 2020 and then surged by 279895.02% in 2022.
  • Over the past 5 years, OptimizeRx's Free Cash Flow (Annual) stood at -$6.4 million in 2020, then soared by 105.67% to $361873.0 in 2021, then soared by 2798.95% to $10.5 million in 2022, then crashed by 176.49% to -$8.0 million in 2023, then surged by 156.72% to $4.6 million in 2024.
  • Its last three reported values are $4.6 million in FY2024, -$8.0 million for FY2023, and $10.5 million during FY2022.